Heat shock protein 70 overexpression does not attenuate atrophy in botulinum neurotoxin type A-treated skeletal muscle

J Appl Physiol (1985). 2015 Jul 1;119(1):83-92. doi: 10.1152/japplphysiol.00233.2015. Epub 2015 May 7.

Abstract

Botulinum neurotoxin type A (BoNT/A) is used clinically to induce therapeutic chemical denervation of spastically contracted skeletal muscles. However, BoNT/A administration can also cause atrophy. We sought to determine whether a major proteolytic pathway contributing to atrophy in multiple models of muscle wasting, the ubiquitin proteasome system (UPS), is involved in BoNT/A-induced atrophy. Three and ten days following BoNT/A injection of rat hindlimb, soleus muscle fiber cross-sectional area was reduced 25 and 65%, respectively. The transcriptional activity of NF-κB and Foxo was significantly elevated at 3 days (2- to 4-fold) and 10 days (5- to 6-fold). Muscle RING-finger protein-1 (MuRF1) activity was elevated (2-fold) after 3 days but not 10 days, while atrogin-1 activity was not elevated at any time point. BoNT/A-induced polyubiquitination occurred after 3 days (3-fold increase) but was totally absent after 10 days. Proteasome activity was elevated (1.5- to 2-fold) after 3 and 10 days. We employed the use of heat shock protein 70 (Hsp70) to inhibit NF-κB and Foxo transcriptional activity. Electrotransfer of Hsp70 into rat soleus, before BoNT/A administration, was insufficient to attenuate atrophy. It was also insufficient to decrease BoNT/A-induced Foxo activity at 3 days, although NF-κB activity was abolished. By 10 days both NF-κB and Foxo activation were abolished by Hsp70. Hsp70-overexpression was unable to alter the levels of BoNT/A-induced effects on MuRF1/atrogin-1, polyubiquitination, or proteasome activity. In conclusion, Hsp70 overexpression is insufficient to attenuate BoNT/A-induced atrophy. It remains unclear what proteolytic mechanism/s are contributing to BoNT/A-induced atrophy, although a Foxo-MuRF1-ubiquitin-proteasome contribution may exist, at least in early BoNT/A-induced atrophy. Further clarification of UPS involvement in BoNT/A-induced atrophy is warranted.

Keywords: Forkhead box O; Foxo; NF-κB; chemical denervation; nuclear factor-κB; protein degradation; ubiquitin proteasome system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Botulinum Toxins, Type A / toxicity*
  • Electroporation
  • Forkhead Transcription Factors / biosynthesis
  • Forkhead Transcription Factors / genetics
  • Gene Expression / drug effects*
  • HSP70 Heat-Shock Proteins / biosynthesis*
  • Hindlimb / pathology
  • Male
  • Muscle Contraction / drug effects
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / pathology*
  • Muscular Atrophy / metabolism
  • NF-kappa B / metabolism
  • Nerve Tissue Proteins / biosynthesis
  • Nerve Tissue Proteins / genetics
  • Peptide Hydrolases / drug effects
  • Peptide Hydrolases / genetics
  • Peptide Hydrolases / metabolism
  • Plasmids / drug effects
  • Plasmids / genetics
  • Proteasome Endopeptidase Complex / metabolism
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Forkhead Transcription Factors
  • HSP70 Heat-Shock Proteins
  • NF-kappa B
  • Nerve Tissue Proteins
  • Foxo1 protein, rat
  • Peptide Hydrolases
  • Botulinum Toxins, Type A
  • Proteasome Endopeptidase Complex